- Company's Quality Commitment Continues
- Undisrupted Distribution of CE Marked Products in European Union
IRVING, Texas, Nov. 14 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today announced that the Company has completed its annual ISO 9001:2000 re-certification inspection at its Irving, Texas location. The inspection was performed by the European Union's notified body, AMTAC Certification Services, Ltd., a division of Intertek Systems Certification. Earlier in 2007, Carrington's wholly-owned subsidiary in Costa Rica, Sabila Industrial, completed its ISO 9001:2000 re-certification inspection.
Dr. Carlton Turner, president and CEO, stated, "Carrington invests a great amount of resources to ensure its quality standards are upheld. Our quality teams in the U.S. and Costa Rica continue to focus on maintaining and improving the Company's quality systems, which defines the standards of all of our raw materials and finished products.
Sabila Industrial manufactures GelSite(R) polymer, the raw material key to the drug and vaccine delivery technology being developed by Carrington's biotech subsidiary DelSite Biotechnologies, Inc. GelSite(R) is the key polymer to formulate the GelVac(TM) influenza nasal powder vaccine for bird flu (H5N1).
Turner continued, "DelSite's vaccine program and working relations with other bio and pharma companies is based on quality in our manufacturing and development areas. Having all formulations and products developed in an ISO facility and under cGMPs provides a solid foundation for future growth of DelSite and our core business."
Carrington's international customer base includes companies who distribute Carrington products in areas of countries such as Italy, France, Portugal, Serbia-Montenegro; with the expansion into countries such as Cypress, Poland and Turkey.
Carrington Laboratories, Inc. is an ISO 9001-certified,
|SOURCE Carrington Laboratories, Inc.|
Copyright©2007 PR Newswire.
All rights reserved